引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 196次   下载 13 本文二维码信息
码上扫一扫!
肝动脉栓塞治疗肝癌最新进展评述
贺庆,官泳松,杨宁宁,熊飞,李肖,张靖宇,谢勇久
0
(四川大学华西医院肿瘤一科;中国医学科学院肿瘤医院介入治疗科)
摘要:
【摘要】肝癌是最常见的恶性肿瘤之一,全球每年有数十万患者死于肝癌。经导管肝动脉化学栓塞(Transcatheter arterial chemoembolization,TACE)是一种临床广泛使用的治疗肝癌的方法。但是,如何通过TACE更好地使肝癌患者获益,仍然存在很多的挑战。本文回顾TACE治疗肝癌的发展过程,并重点就TACE栓塞剂以及TACE联合其他抗肿瘤方式治疗肝癌的最新进展做一评述。
关键词:  肝细胞癌  动脉化学栓塞  栓塞剂  联俣治疗
DOI:
基金项目:国家自然科学基金面上项目(81171444)
Treatment of early stage avascular necrosis of the femoral head
HE Qing,GUAN Yongsong,YANG Ningning,XIONG Fei,LI Xiao,ZHANG Jingyu,XIE Yongjiu
(Department of Oncology, West China Hospital of Sichuan University)
Abstract:
【Abstract】Hepatocellular carcinoma is a lethal disease that kills several homchad thousands of thousands of people every year across the globe. Transcatheter arterial chemoembolization(TACE) is a widely used approach in clinical practice to treat hepatocellular carcinoma(HCC). However, we are now facing many challenges in the field of improving the survival outcomes of TACE for the treatment of HCC. This paper reviews recent advances in TACE treatment of HCC with the highlights of newly developed embolization agents and combiantion use of TACE and other treatment methods to get improved outcome of patients with HCC.
Key words:  Combination  Hepatocellular carcinoma  Transcatheter arterial chemoembolization  Embolization agents  treatment

用微信扫一扫

用微信扫一扫